U.S. plans to allow prescription drug imports from Canada

U.S. plans to allow prescription drug imports from Canada
U.S. plans to allow prescription drug imports from Canada
The White House announced the plan today to let Americans import prescription medication from Canada, which has left some of the side of the Border concerned about possible knock-on effects to Canada’s pharmaceutical synthesis system rather than with us for more hi Katie. The Trump Administration proposals ever ways to safely import drugs that are less expensive into the United States from Canada T’s Market. This is a massive concern in the United States. Just to give you one example: the cost of insulin in the United States is roughly 10 times higher than what it is in Canada. I was speaking with someone today, but at the cost of insulin – and she explained to me that Canadians can spend anywhere out-of-pocket 302. Are $ 150 to $ 300 a month on insulin, or is the United States closer to 1,500 to $ 3,000 a month, so understandably in this is always been a massive election issue in the United States given to challenges around healthcare costs, drug prices. So today, as the Democrats are, holding a series of debates and and Healthcare has a massive issue that they want. A campaign on the Trump Administration comes out with this announcement saying that it will look at some of these proposed. What states can come forward to make a proposal on different organ? At pharmacies can come forward to make proposal at on ways to ensure that safe drugs are getting into the United States, and perhaps it do cost less, whether they’re coming from Canada or other places. There has been a lot of pushback from the pharmaceutical Lobby in the u.s.. It is incredibly powerful and that’s why some of these drug prices have been allowed to go unchecked for so long. So there are questions about whether this will actually be affect. How quickly any changes could actually happen? Getting things approved in the United States could take months to years, and some American news outlets are reporting. It’S very likely they’re going to get challenged in the courts. White House has its open braided some questions on this side of the Border. What are the concerns being raised here in Canada and by who, and their big concern is how are Canadian, how? How are Canadian pharmacists going to stay stocked with appropriate amounts of medication? If the Americans, which is a much larger market, are trying to tap into that, the other concern is that we spoke with Kimberly Hanson from diabetes, Canada. There are concerns right now. There is a drug shortage problem in Canada, even though we spoke with diabetes, Canada. The shortage is not a boat insulin, but in general there are shortages in there concerns until we ask her about this and have listened. We know that Health, Canada and other agencies monitor drug shortages on an ongoing basis. So we do have comfort that there is a safety net in place, but we have heard very res believe that there have been some small, temporary local shortages that show that there can be a real problem when you think about an entire state or multiple States. Being able to bulk import insulin concern here is whether it’s a different, whether it’s different drugs or whether things are imported in bulk, is not necessarily. You know. The Caravans coming across the border to individually by insulin at a pharmacy stay in Windsor Ontario in a Border Town there initial response to this Health Minister. She was at the Delta hotel earlier today, but then died was not available for anything on camera, but she did put it in a little bit later. There are no adverse effects to the supply or cost of prescription drugs in Canada were in touch with you as officials, and look forward to discussing today’s announcement with them. I spoke with a source that told me there was no immediate heads up a source with direct knowledge of the situation, but how they’re, having a larger conversation about this was not necessarily a surprise, but that’s where it is about this new policy in the u.s.. What should policymakers here dr. Joel election is a professor emeritus at the school of health policy and management. New York University joins me now from Toronto. Hi. Nice to see you this morning. Do you think, will it work opposing – and I know it’s kind of basic at this point – not too detailed but actually lower the price of drugs in the United States for a number of reasons? First of all, it’s not going to apply to the really expensive products like the biologics, we’re talking here about things like Humira or Remicade, drugs that are being used to treat various forms of arthritis, slimeatory, bowel disease. Those are biologics. They run in the range of 30 to $ 40,000 they’re, not going to be covered, insulin, isn’t going to be covered and the United States every drug in and it still wouldn’t solve their problem because, as Katie Simpson was saying, they’re ten times larger than us, the Main problem in the United States with drug prices is that they rely on the market and when we were talking about brand-name drugs, the ones that are really expensive, brand-name drugs, because they’re covered by a patent don’t have any competition and the United States, unlike every other Western Country doesn’t negotiate prices with the with the Drudge. Is they let the market Run free and the market just doesn’t work icon drug Supply in this country? What do you think of those concerns you have to distinguish between generic and brand-name drugs? It’S the generics that are in that that we have drug shortages and because there are more companies making generics in the United States and more competition, generic prices in the US tend to be lower than ours, so they from Canada going to be importing brand name. Drugs. Caravans by led by Bernie Sanders are other people that come across the border. A hundred people 200 paintball supply in Canada. It’S the large-scale importing by US states for civil servants or their Medicaid population. Medicaid is the plan that covers people in low-income. That’S if they’re importing large quantities, brand name drugs, that’s where we could potentially see a problem because they could because they’re negotiating because of their size to us California, wants to impart. As I said, there goes the entire drug Supply potentially of Canada Hill. What does the federal government do in response and what kinds of things should policymakers be looking at doing in respond from the purely Canadian perspective, I think that what we should be doing is talking about limiting the exports to the US to acai to an amount that Would still guarantee that there is an addict supply of the brand-name drugs here in Canada. On a larger perspective, I mean Ottawa should be, could be talking to the us about what we do to keep our drug prices low and encouraging the American to emulate. What we do and what every other Western Country does, that we still have the adequate Supply brand name drug. Is that something that? How would that work I mean? Would you would they just impose that? Would there be? I know it’s a little considerations, considering the relationship with the us, but aside from those that work. Well, I’m not a I’m, not a trade lawyer, so I can’t give you the details, but my understanding is that Ottowa does does have the power could give itself the power to posed. I’M export restrictions on prescription drugs. I’M sorry! I can’t go any further. The drug shortage in this country and you qualified again the difference between generic and brand-name drugs. Can you can you explain to us a bit about what that drug shortage looks like and what the the I guess with the consequences of it are even at this juncture, regardless of what the US decide. Barely talking about generic drugs, generic drugs have lower profit margins than brand-name drugs to your generic company. You make 10 drugs. Five of them have a good profit margin on five of them. You may decide to cut back on the 5 that don’t give you a lot of that. Don’T give you a lot of money. The other problem is that the large drug companies and the generic companies for reasons of Economics are Outsourcing their supply of the active ingredients. This is a part of the drug that actually does the work and those active ingredients primarily are being made in China or India where there are looser manufacturing standards. There often problems discovered in the factories, something happens. You can’t get your drugs coming from those factories, and you end up with a drug shortage. Cappello’S host of Power & politics see more of our show by subscribing to the CBC News Channel or click the link for another video thanks for watching
Donald Trump’s administration plans to allow the importing of cheaper prescription drugs from Canada, but the plan is causing concerns about possible drug shortages among Canadians.
To read more: http://cbc.ca/1.5232360

»»» Subscribe to CBC News to watch more videos: http://bit.ly/1RreYWS

Connect with CBC News Online:

For breaking news, video, audio and in-depth coverage: http://bit.ly/1Z0m6iX
Find CBC News on Facebook: http://bit.ly/1WjG36m
Follow CBC News on Twitter: http://bit.ly/1sA5P9H
For breaking news on Twitter: http://bit.ly/1WjDyks
Follow CBC News on Instagram: http://bit.ly/1Z0iE7O

Download the CBC News app for iOS: http://apple.co/25mpsUz
Download the CBC News app for Android: http://bit.ly/1XxuozZ

»»»»»»»»»»»»»»»»»»
For more than 75 years, CBC News has been the source Canadians turn to, to keep them informed about their communities, their country and their world. Through regional and national programming on multiple platforms, including CBC Television, CBC News Network, CBC Radio, CBCNews.ca, mobile and on-demand, CBC News and its internationally recognized team of award-winning journalists deliver the breaking stories, the issues, the analyses and the personalities that matter to Canadians.

Leave a Reply

Your email address will not be published. Required fields are marked *